Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heming

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2023
Learning multiple sclerosis immunopathogenesis from anti-CD20 therapyMichael Heming, Heinz Wiendl
Genome Medicine|August 17, 2022
High-dimensional investigation of the cerebrospinal fluid to explore and monitor CNS immune responsesMichael Heming, Anna-Lena Börsch, Heinz Wiendl, et al.
Journal of Neuroimmunology|April 16, 2023
Alemtuzumab treatment exemplifies discordant immune effects of blood and cerebrospinal fluid in multiple sclerosisLouisa Müller-Miny, Michael Heming, Tobias Lautwein, et al.
Journal of Clinical Medicine|October 9, 2019
Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs-A Systematic ReviewLeoni Rolfes, Steffen Pfeuffer, Tobias Ruck, et al.
Journal of Neuroimmunology|February 3, 2020
Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosisMichael Heming, Lisa Lohmann, Andreas Schulte-Mecklenbeck, et al.
Ebiomedicine|August 3, 2019
Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort studyTobias Ruck, Andreas Schulte-Mecklenbeck, Steffen Pfeuffer, et al.
Frontiers in Immunology|June 6, 2018
Peroxisome Proliferator-Activated Receptor-γ Modulates the Response of Macrophages to Lipopolysaccharide and GlucocorticoidsMichael Heming, Sandra Gran, Saskia-L Jauch, et al.
Frontiers in Genetics|September 5, 2024
Case report: Clinical, genetic and immunological characterization of a novel <i>XK</i> variant in a patient with McLeod syndromeChristine Anna Dambietz, Andrea Doescher, Michael Heming, et al.
BMC Neurology|July 3, 2024
Severe CSF immune cell alterations in cryptococcal meningitis gradually resolve during antifungal therapyChristine Dambietz, Michael Heming, Tobias J Brix, et al.
BMC Neurology|July 17, 2025
Extracorporeal therapy procedures (plasma exchange and immunoadsorption) in chronic inflammatory demyelinating polyneuropathies (CIDP)- a database analysisMoritz Mahlberg, Johannes Dorst, Zeynep Elmas, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2023
Learning multiple sclerosis immunopathogenesis from anti-CD20 therapyMichael Heming, Heinz Wiendl
Genome Medicine|August 17, 2022
High-dimensional investigation of the cerebrospinal fluid to explore and monitor CNS immune responsesMichael Heming, Anna-Lena Börsch, Heinz Wiendl, et al.
Journal of Neuroimmunology|April 16, 2023
Alemtuzumab treatment exemplifies discordant immune effects of blood and cerebrospinal fluid in multiple sclerosisLouisa Müller-Miny, Michael Heming, Tobias Lautwein, et al.
Journal of Clinical Medicine|October 9, 2019
Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs-A Systematic ReviewLeoni Rolfes, Steffen Pfeuffer, Tobias Ruck, et al.
Journal of Neuroimmunology|February 3, 2020
Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosisMichael Heming, Lisa Lohmann, Andreas Schulte-Mecklenbeck, et al.
Ebiomedicine|August 3, 2019
Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort studyTobias Ruck, Andreas Schulte-Mecklenbeck, Steffen Pfeuffer, et al.
Frontiers in Immunology|June 6, 2018
Peroxisome Proliferator-Activated Receptor-γ Modulates the Response of Macrophages to Lipopolysaccharide and GlucocorticoidsMichael Heming, Sandra Gran, Saskia-L Jauch, et al.
Frontiers in Genetics|September 5, 2024
Case report: Clinical, genetic and immunological characterization of a novel <i>XK</i> variant in a patient with McLeod syndromeChristine Anna Dambietz, Andrea Doescher, Michael Heming, et al.
BMC Neurology|July 3, 2024
Severe CSF immune cell alterations in cryptococcal meningitis gradually resolve during antifungal therapyChristine Dambietz, Michael Heming, Tobias J Brix, et al.
BMC Neurology|July 17, 2025
Extracorporeal therapy procedures (plasma exchange and immunoadsorption) in chronic inflammatory demyelinating polyneuropathies (CIDP)- a database analysisMoritz Mahlberg, Johannes Dorst, Zeynep Elmas, et al.
Pageof 4